Celldex Therapeutics Inc (CLDX) — Cash Flow Reinvestment Rate
Celldex Therapeutics Inc (CLDX) has a Cash Flow Reinvestment Rate of 0.02x as of December 2008, reinvesting $26.75K (capex $26.75K ) from operating cash flow of $1.29 Million. See Celldex Therapeutics Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Celldex Therapeutics Inc Cash Flow Reinvestment Rate (1986–2008)
Historical reinvestment intensity for Celldex Therapeutics Inc across 3 annual periods. For the full cash flow conversion analysis, see CLDX cash flow metrics.
Annual Cash Flow Reinvestment Rate for Celldex Therapeutics Inc (1986–2008)
Year-by-year capital reinvestment analysis for Celldex Therapeutics Inc. See how financially flexible is Celldex Therapeutics Inc to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2008 | 0.07x | $1.30 Million | $18.28 Million | $1.30 Million | ▼ -79.3% |
| 2006 | 0.35x | $9.32 Million | $27.00 Million | $9.32 Million | — |
| 1986 | 0.00x | $0.00 | $12.30 Million | $0.00 | — |